Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
09 Regulatory Status No regulator approves BPC-157 for any indication
Always work with your healthcare provider to find the right balance between efficacy and tolerability
Generic appearance descriptions cannot be relied upon, as they may vary between formulations
Lifestyle Factors : Identify habits like smoking or high alcohol intake that could compromise healing or elevate risk
COA / Lab results Evidence: Preclinical Pros Selective, membrane-permeable NNMT inhibitor Raises intracellular NAD+ and SAM by blocking the methylation sink Reduced weight and fat mass in diet-induced obese mice Activates sirtuin pathways associated with metabolic health Cons Evidence entirely preclinical (cell/mouse)
AOD 9604 does not share this effect
US$ 25.54
US$ 26.71
US$ 20.98
US$ 27.19
